AgomAb Therapeutics
Xavier Van Rillaer serves as the Head of Finance and Controlling at AgomAb Therapeutics since September 2021. Previously, Xavier held the position of Auditor - Capital Markets at BDO Belgium - UK from February 2016 to September 2021 and worked as an Accountant at Carconnex between October 2014 and January 2016. Xavier Van Rillaer earned a Master of Business Administration (MBA) from Vlerick Business School.
This person is not in any offices
AgomAb Therapeutics
AgomAb is pioneering therapies that modulate regenerative pathways to achieve structural tissue repair and functional organ recovery.